Forum

× click new topic to start your post

FDA Accelerated Approval for Padcev - (Enfortumab-vedotin)

4 months 2 weeks ago #58886 by Jack R
News from late December 2019,

FDA Approves Padcev (enfortumab vedotin-ejfv) for Locally Advanced or Metastatic Urothelial Cancer, the Most Common Type of Bladder Cancer.

Another option to look into for those of us who are not good surgical candidates. I could not join the study because of other medical problems, but it was one of two that looked promising.
Info at

https://www.drugs.com/newdrugs/fda-approves-padcev-enfortumab-vedotin-ejfv-locally-advanced-metastatic-urothelial-cancer-most-5125.html

Best to all,
Jack

What's with this Bleeding ? 6/2015
DX: HG Papillary & CIS
3 Years and 30 BCG/BCG+Inf
Tis CIS comes back.
BC clear as of 5/17 !
RCC found in my one & only kidney 10/17
Begin Chemo; Cisplatin and Gemzar
8/18 begin Chemo# 3
Begin year 4 with cis
2/19 Chemo #4
9/19 NED again :)
1/2020 CIS is back...

Please Log in or Create an account to join the conversation.

  • Not Allowed: to create new topic.
  • Not Allowed: to reply.
  • Not Allowed: to add Files.
  • Not Allowed: to edit your message.
Moderators: Cynthiaeddieksara.anne

Users

Total Online: 0 Users and 2226 Guests 

Statistics

Today Total Opened: 0 Today Total Answered: 0 Latest User: Firefly
Yesterday Total Opened: 0 Yesterday Total Answered: 0
Total Posts: 53690 Total Subjects: 7028 Total Users: 8726